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Introduction
The overall incidence of chronic obstructive
pulmonary disease (COPD) is increasing and
negatively affecting the quality of life of the
patient.
Chronic obstructive pulmonary disease is
associated with a high morbidity and
mortality rate and is currently the 4th
leading cause of death in the United States
and is projected to be the 3rd by 2020
(Schnell, K., et al., 2012).

What is COPD
Chronic obstructive pulmonary disease is said to be a preventable and treatable disease;
not reversible (Halldin, Doney, & Hnizdo, 2015).
A description of COPD is provided by the Centers for Disease Control and Prevention
(CDC) as a group of lung diseases which causes a progressive blockage of expiratory air
flow. The subtypes of COPD is inclusive of: asthma, chronic bronchitis, and emphysema.

Asthma
•

Due to the high incidence and chronicity of
COPD, patients frequently present for
treatment , often face hospital admissions
related to acute exacerbations, and require
life-long treatment for disease management
(Han, Dransfield, & Martinez, 2017).
Because of this, the family nurse
practitioner (FNP) will without a doubt
encounter and provide treatment for a
patient with COPD.

•

This is further supported by Yawn, Wollan,
Trextor, and Yawn (2016) who state COPD
is common and most patients diagnosed
with COPD receive care from their primary
care providers and most recently from
nurse practitioners and physician’s
assistants. Due to the prevalence of COPD
and those presenting for treatment, the FNP
will need to have an understanding of the
disease process to better serve the patient.

•

Rennard et al. (2013) states COPD is said to
be unappreciated with half of the COPD
patients being undiagnosed or
undertreated.

•

•
•
•
•
•

•

A variable inflammation of the airways with hypersecretion of mucous and
bronchial constriction causing airflow obstruction.
Exposure to irritants is the primary trigger of asthma and avoidance of these
irritants is key.
Large familial incidence of asthma.
IgE is thought to be a contributor to the pathophysiologic characteristics of asthma.
Exposure to antigens cause epithelial damage, basement membrane thickening,
and eosinophil infiltrates into the walls of the airways.
There is an influx of neutrophils, eosinophils, mast cells, and tumor necrosis
factor- alpha.
Inflammatory and pro-inflammatory mediators cause epithelial damage, mucous
plugging, and increased endothelial permeability causing airway edema.
(Lugogo & MacIntyre, 2008).
The presence of CD4+ T-lymphocytes, eosinophils, and increased interleukin (IL)-4
and IL5 is characteristic of the bronchial inflammation seen in asthma (Han,
Dransfield, & Martinez, 2017).
The individual signs and symptoms of asthma are: sporadic chest tightness, cough,
wheezing, and shortness of breath with fluctuating and reversible airflow
obstruction; not all wheezing is asthma and not all asthma wheezes (Halldin,
Doney, & Hnizdo, 2015).

Chronic Bronchitis

•
•
•

The pathophysiologic process of bronchitis is triggered by irritants which cause
airway inflammation; the largest contributing factor being cigarette smoke.
Inflammation and thickening of the bronchial tubes with a hypersecretion of
mucus.
There is an overproduction of mucous due to an increased amount and size of
goblet cells and enlarged submucosal glands.
The individual signs and symptoms of bronchitis are: activity intolerance ,
shortness of breath, and chronic cough lasing for a minimum of three months in
two consecutive years.
(Han, Dransfield, & Martinez, 2017).

Emphysema
•
•
•
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Signs and Symptoms of COPD

Pathophysiology

•
•

Destruction of structures distal to the terminal bronchial which include the
respiratory bronchial, alveolar ducts, sacs, and alveoli; collectively the acinus.
Abnormal, irreversible enlargement of the terminal airspaces which accompanies
destruction of the alveolar walls. The elasticity of the lung is lost resulting in
airflow obstruction.
The individual signs and symptoms of emphysema are: weight loss- thought to be
due to the increased metabolic demands of breathing with use of accessory
muscles, shortness of breath with activity eventually advancing to shortness of
breath while at rest, non-productive cough, and a prolonged period of expiration.
(Han, Dransfield, & Martinez, 2017).
Major contributing factor of the development of emphysema is cigarette smoke.
Genetic risk factor identified in emphysema: Alpha 1-antitriypsin (ATT) deficiency.
(Bauldoff, 2012).

The changes associated with COPD are primarily seen in the airways, lungs, and
pulmonary vasculature. The changes and their pathologic processes are
dependent upon the underlying disease, susceptibility to, and severity of the
disease.
Collectively, the signs and symptoms of COPD include: dyspnea, activity
intolerance, chronic productive or non-productive cough, wheezing, and chest
tightness.
Gradual onset of the symptoms tend to contribute to the underdiagnosis of COPD
as these symptoms are often common in presentation of other diseases.
(Han, Dransfield, & Martinez, 2017).

Significance of Pathophysiology
and Its Implications for
Nursing Care
For the ANP to know the manifestations and progression of
COPD, there needs to first be an understanding of its
pathophysiology to guide the correct diagnosis and appropriate
treatment to prevent disease progression and complications.
•

Risk Factors for COPD
•
•
•
•
•
•
•

Cigarette smoking and second hand exposure to cigarette smoke.
- The most significant factor of the development and progression of COPD.
Air pollution
Reduced lung development or frequent and severe lung infections during
childhood.
History of asthma
Lower socioeconomic status
Poor nutrition
Genetic risk factor of ATT deficiency
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•
•

Provide risk reduction education:
- Smoking cessation and avoidance of other irritant
exposures
- Vaccines against respiratory infections
- Appropriate nutrition
- Medication compliance and proper use
- Self care and symptom management
(Garvey, 2011).
For all COPD patients, short acting beta agonists and/or
anticholinergic bronchodilator use is recommended to
improve symptoms and lung function
Long acting beta agonists are used for more symptomatic
patients
(Ferguson, 2017).

The management of COPD is difficult. The advanced nurse
practitioner (ANP) will need to maximize each patient visit to
provide education of proper medication compliance and inhaler
use while assisting and providing education where needed.
The nurse will be involved in the diagnosis of COPD by
performing spirometry and testing; patient education is key to
obtaining accurate results.
Since smoking is the major contributing factor, smoking
cessation and support is an integral part of care.
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Exacerbations are common and the patient will need to be
educated of the signs and symptoms and when to present for
treatment to avoid a hospital admission.
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Exercise and nutrition should be included in the care of the
COPD patient. Obesity will increase the work load of the patient
while those who are underweight have shown to have a poor
prognosis.

Schnell, K., O Weiss, C., Lee, T., Krishnan, J. A., Leff, B., Wolff, J. L., & Boyd, C. (2012).
The prevalence of clinically-relevant comorbid conditions in patients with physician
diagnosed COPD: A cross-sectional study using data from NHANES 1999-2008. BMC
Pulmonary Medicine, 12:26.

Anxiety and depression are common, the APN will need to
provide support and education to the patient and family.
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